EUVIMEDEUVIMED entdecken
Crossref

Is milbemycin a game changer against antifungal drug-resistant mycoses?

Rui Kano iD, Tsuyoshi Yamada, Takashi Tamura, Koichi Makimura

Medical Mycology · 2024

DOI: 10.1093/mmy/myae003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, 2024. Verfasst von Rui Kano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Teikyo University Institute of Medical Mycology (TIMM), 359 Otsuka, Hachioji, Tokyo 192-0395, Japan. Hauptthemen laut MEDLINE: Mycoses, Cryptococcus neoformans, Macrolides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: JSPS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Milbemycin oximes are macrocyclic lactones that have a broad spectrum of activity against nematode infection in animals. They are known to block drug efflux, which increases the susceptibility of fungi to azoles. We investigated the effects of milbemycin on the azole susceptibility of fungi (Aspergillus fumigatus, Candida albicans, C. auris, Cryptococcus neoformans, and Trichophyton rubrum). To screen for changes in azole susceptibility, fungal growth was tested on a culture medium containing 1 μg/ml milbemycin. The results showed that milbemycin increased the azole susceptibility of azole-resistant strains of C. albicans, C. auris, C. neoformans, and T. rubrum. Thus, milbemycin might be useful against antifungal drug-resistant strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MycosesCryptococcus neoformansMacrolidesAnimalsAntifungal AgentsDrug Resistance, FungalAzolesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

ATP-binding cassette transporter proteinantifungal drug resistancemilbemycinmycoses

Substanzen

Antifungal AgentsmoxidectinAzolesMacrolides

Autor:innen und Institutionen

  • Teikyo University Institute of Medical Mycology (TIMM), 359 Otsuka, Hachioji, Tokyo 192-0395, Japan.
  • General Medical Education and Research Center, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.

ORCID-Profile: Rui Kano

Förderung

  • JSPS

Zitieren

APA

Kano, R., Yamada, T., Tamura, T., & Makimura, K. (2024). Is milbemycin a game changer against antifungal drug-resistant mycoses?. Medical Mycology. https://doi.org/10.1093/mmy/myae003

Vancouver

Kano R, Yamada T, Tamura T, Makimura K. Is milbemycin a game changer against antifungal drug-resistant mycoses?. Medical Mycology. 2024. doi:10.1093/mmy/myae003

BibTeX
@article{Kano2024,
  author = {Kano, Rui and Yamada, Tsuyoshi and Tamura, Takashi and Makimura, Koichi},
  title = {Is milbemycin a game changer against antifungal drug-resistant mycoses?},
  journal = {Medical Mycology},
  year = {2024},
  doi = {10.1093/mmy/myae003}
}
Kostenlos starten →